Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993)
      QxMD      Google Scholar   
Citation:
Support Care Cancer vol 20 (8) 1729-1735
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
1
Parents:
410  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
K05 CA124477, K05 CA124477-03, U10 CA025224, U10 CA037404  
Corr. Author:
 
Authors:
               
Primary Study
N0993
Secondary Studies:
Phases:
N/A
Keywords:
Skindex-16, CTCAE, Dermatitis, Patient-reported outcomes, Cytotoxic treatment-induced dermatitis